Thomas Verron

A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic profiles of cigarettes and e-cigarettes with nicotine salt formulations in US adult smokers

Grant C. O’Connell, J. Pritchard, Chris Prue et al. · Internal and Emergency Medicine · 2019 · 108 citations · Full text

Tobacco Control, Substance Abuse, Nicotine Salts +14

Perception of the relative harm of electronic cigarettes compared to cigarettes amongst US adults from 2013 to 2016: analysis of the Population Assessment of Tobacco and Health (PATH) study data

Layla Malt, Thomas Verron, Xavier Cahours et al. · Harm Reduction Journal · 2020 · 47 citations · Full text

Some theoretical properties of the O‐PLS method

Thomas Verron, Robert Sabatier, Richard Joffre · Journal of Chemometrics · 2004 · 44 citations

Numerical Analysis, Numerical Computation, Engineering +13

Reductions in biomarkers of exposure to selected harmful and potentially harmful constituents following exclusive and partial switching from combustible cigarettes to myblu™ electronic nicotine delivery systems (ENDS)

Paul W. Morris, Simon McDermott, Fiona Chapman et al. · Internal and Emergency Medicine · 2021 · 35 citations · Full text

Supervised component generalized linear regression using a PLS-extension of the Fisher scoring algorithm

Xavier Bry, Catherine Trottier, Thomas Verron et al. · Journal of Multivariate Analysis · 2013 · 23 citations

Data Classification, Support Vector Machine, Classification Method +9